| 24726882 | Induction of ATM/ATR pathway combined with Vγ2V??2 T cells enhances cytotoxicity of ovarian cancer cells. | Biochim Biophys Acta | 2014 Jul | Lu J | doi: 10.1016/j.bbadis.2014.04.003 |
| 11865061 | Hypoxia links ATR and p53 through replication arrest. | Mol Cell Biol | 2002 Mar | Hammond EM | - |
| 22341969 | Germline mutation in ATR in autosomal- dominant oropharyngeal cancer syndrome. | Am J Hum Genet | 2012 Mar 9 | Tanaka A | doi: 10.1016/j.ajhg.2012.01.007 |
| 15282542 | ATR functions as a gene dosage-dependent tumor suppressor on a mismatch repair-deficient background. | EMBO J | 2004 Aug 4 | Fang Y | - |
| 27693461 | Inhibition of ATR-dependent feedback activation of Chk1 sensitises cancer cells to Chk1 inhibitor monotherapy. | Cancer Lett | 2016 Dec 1 | Massey AJ | doi: 10.1016/j.canlet.2016.09.024 |
| 28273450 | ATR Mutations Promote the Growth of Melanoma Tumors by Modulating the Immune Microenvironment. | Cell Rep | 2017 Mar 7 | Chen CF | doi: 10.1016/j.celrep.2017.02.040. |
| 26748709 | Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities. | Cell Rep | 2016 Jan 12 | Sanjiv K | doi: 10.1016/j.celrep.2015.12.032 |
| 18625709 | ATR-dependent activation of p38 MAP kinase is responsible for apoptotic cell death in cells depleted of Cdc7. | J Biol Chem | 2008 Sep 12 | Im JS | doi: 10.1074/jbc.M802851200 |
| 21308861 | Inhibition of ataxia telangiectasia- and Rad3-related function abrogates the in vitro and in vivo tumorigenicity of human colon cancer cells through depletion of the CD133(+) tumor-initiating cell fraction. | Stem Cells | 2011 Mar | Gallmeier E | doi: 10.1002/stem.595. |
| 24752797 | Development of serous ovarian cancer is associated with the expression of homologous recombination pathway proteins. | Pathol Oncol Res | 2014 Oct | Ye Q | doi: 10.1007/s12253-014-9776-8 |
| 26755646 | A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancers. | Oncotarget | 2016 Feb 9 | Hocke S | doi: 10.18632/oncotarget.6857. |
| 21034966 | The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. | Adv Cancer Res | 2010 | Smith J | doi: 10.1016/B978-0-12-380888-2.00003-0. |
| 20513533 | High incidence of mutations in BRCA1 and BRCA2 genes in ovarian cancer. | Bull Exp Biol Med | 2007 Jul | Smirnova TY | - |
| 23548269 | Germline mutations of BRCA1 gene exon 11 are not associated with platinum response neither with survival advantage in patients with primary ovarian cancer: understanding the clinical importance of one of the biggest human exons. A study of the Tumor Bank Ovarian Cancer (TOC) Consortium. | Tumour Biol | 2016 Sep | Dimitrova D | - |
| 25468710 | Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer. | Mol Oncol | 2015 Mar | Abdel-Fatah TM | doi: 10.1016/j.molonc.2014.10.013 |
| 23844225 | Associations of ATR and CHEK1 single nucleotide polymorphisms with breast cancer. | PLoS One | 2013 Jul 3 | Lin WY | doi: 10.1371/journal.pone.0068578 |
| 26486089 | Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition. | Oncotarget | 2015 Oct 20 | Middleton FK | doi: 10.18632/oncotarget.6136. |
| 18642075 | Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and p53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers. | Breast Cancer Res Treat | 2009 Jul | Kontorovich T | doi: 10.1007/s10549-008-0121-3 |
| 23451157 | Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells. | PLoS One | 2013 | Sultana R | doi: 10.1371/journal.pone.0057098 |
| 26517239 | The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo. | Oncotarget | 2015 Dec 29 | Vendetti FP | doi: 10.18632/oncotarget.6247. |
| 23600770 | HY-1 induces G(2)/M cell cycle arrest in human colon cancer cells through the ATR-Chk1-Cdc25C and Weel pathways. | Cancer Sci | 2013 Aug | Zhao Y | doi: 10.1111/cas.12182 |
| 21383502 | Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells. | J Clin Invest | 2011 Apr | Connell CM | doi: 10.1172/JCI43976 |
| 22435685 | Novel regulation of checkpoint kinase 1: Is checkpoint kinase 1 a good candidate for anti-cancer therapy? | Cancer Sci | 2012 Jul | Goto H | doi: 10.1111/j.1349-7006.2012.02280.x |
| 26657501 | ATR-Chk1 signaling inhibition as a therapeutic strategy to enhance cisplatin chemosensitivity in urothelial bladder cancer. | Oncotarget | 2016 Jan 12 | Li CC | doi: 10.18632/oncotarget.6482. |
| 21566061 | Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage. | Mol Cancer Ther | 2011 Jul | Ha K | doi: 10.1158/1535-7163.MCT-11-0094 |
| 23284306 | A synthetic interaction screen identifies factors selectively required for proliferation and TERT transcription in p53-deficient human cancer cells. | PLoS Genet | 2012 | Xie L | doi: 10.1371/journal.pgen.1003151 |
| 25336189 | Identification of ATR-Chk1 pathway inhibitors that selectively target p53-deficient cells without directly suppressing ATR catalytic activity. | Cancer Res | 2014 Dec 15 | Kawasumi M | doi: 10.1158/0008-5472.CAN-14-2650 |
| 19477925 | Estrogen inhibits ATR signaling to cell cycle checkpoints and DNA repair. | Mol Biol Cell | 2009 Jul | Pedram A | doi: 10.1091/mbc.E09-01-0085 |
| 15374968 | Inhibition of ATR leads to increased sensitivity to hypoxia/reoxygenation. | Cancer Res | 2004 Sep 15 | Hammond EM | - |
| 25846551 | Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study. | Ann Oncol | 2015 Jul | Beltrame L | doi: 10.1093/annonc/mdv164 |
| 28440428 | Inhibition of ATR potentiates the cytotoxic effect of gemcitabine on pancreatic cancer cells through enhancement of DNA damage and abrogation of ribonucleotide reductase induction by gemcitabine. | Oncol Rep | 2017 Jun | Liu S | doi: 10.3892/or.2017.5580 |
| 27472395 | IGF-1R inhibition sensitizes breast cancer cells to ATM-related kinase (ATR) inhibitor and cisplatin. | Oncotarget | 2016 Aug 30 | O'Flanagan CH | doi: 10.18632/oncotarget.10862. |
| 29378956 | ATR-Chk1 activation mitigates replication stress caused by mismatch repair-dependent processing of DNA damage. | Proc Natl Acad Sci U S A | 2018 Feb 13 | Gupta D | doi: 10.1073/pnas.1720355115 |
| 28017652 | ATR gene mutations in HPV negative oropharyngeal cancer. | Oral Oncol | 2017 Feb | Jeannon JP | doi: 10.1016/j.oraloncology.2016.12.009 |
| 29396668 | Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy. | Breast Cancer Res Treat | 2018 Jun | Al-Subhi N | doi: 10.1007/s10549-018-4683-4 |
| 28808232 | Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression. | Sci Rep | 2017 Aug 14 | Di Benedetto A | doi: 10.1038/s41598-017-07366-7. |
| 30532030 | Genome-wide CRISPR screens reveal synthetic lethality of RNASEH2 deficiency and ATR inhibition. | Oncogene | 2019 Apr | Wang C | doi: 10.1038/s41388-018-0606-4 |
